Navigation Links
Clinical Study Demonstrates Superior Bioavailability of Jarrow's Proprietary QH-absorb Formula
Date:6/13/2009

Clinical study demonstrates superior bioavailability of Jarrow Formula's proprietary ubiquinol Co-Q10 formula

Los Angeles, CA (PRWEB) June 13, 2009 -- The results of a clinical trial investigating the bioavailability of Jarrow Formulas®' QH-absorb®, a stabilized proprietary Co-Q10 formula utilizing the reduced form of Co-Q10 called ubiquinol, on 11 adult volunteers, was recently concluded at the medical school of the University of Ancona in Ancona, Italy.

Italian scientists from the University of Ancona (Institute of Biochemistry) measured the plasma level of Co-Q10 after taking 100 mg three times per day (100 mg T.I.D. = 300 mg). Eleven adult volunteers took Jarrow Formulas®' proprietary QH-absorb® formula over a 2-week period.

In this study, the results proved the superior absorption of QH-absorb®, as demonstrated by:

 
  • total Co-Q10 levels increasing from 0.70 mcg/mL to 6.14 mcg/mL.
  • improving the mean reduced Co-Q10 (ubiquinol) levels in the plasma from .62 mcg/ml to 5.75 mcg/mL. This was an increase of 827% over baseline in humans.
  • 5 of the volunteers achieved plasma levels over 7 mcg/mL and one subject was higher than 8 mcg/mL.

Another interesting finding showed a significant reduction in oxidized Co-Q10 in patients. Oxidized Co-Q10 does not function as an antioxidant. The results proved the efficacy of
'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. IFX anti-TNF therapy associated with clinical benefit over 5 years in patients with active AS
2. Subclinical markers predict relapse in juvenile idiopathic arthritis post methotrexate withdrawal
3. Clinical Innovations Introduces New Circumcision Device
4. New Directions in Angioedema: A Focus on Etiologies and Clinical Approach
5. DaVita Study Demonstrates Clinical Application of Sysmex Reticulocyte Hemoglobin Equivalent (RET-He) Parameter
6. Medifocus, Inc. receives Authorization Approval from Health Canada to launch its pivotal Phase III clinical study of focused microwave heating for treatment of breast cancer in Canada
7. Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study
8. Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281
9. Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-7851 in Chronic Hepatitis C Patients
10. ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe
11. Ross University School of Medicine Expands Clinical Rotations in Miami
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... ... August 01, 2015 , ... BeverlyD, owner and founder of BeverlyD Luxe ... the very first small business donation to kick off the campaign for healing and ... Her legacy includes a complete line of raw, organic hair care products, as well ...
(Date:7/31/2015)... York (PRWEB) , ... July 31, 2015 , ... When ... their stuff, Super-Sod debuted their new type of sod called Leisure Time(TM) zoysia ... application in process. , To commemorate introduction of this new type of sod, Super-Sod ...
(Date:7/31/2015)... GA (PRWEB) , ... July 31, 2015 , ... ... five new industry players to know in predictive health analytics , Jvion ... learning technologies. The firm creates predictive software that targets patient and population level ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... at its new True North Conference Center. The medical community, social workers, law ... community may be more aligned in the effort to better understand and combat ...
(Date:7/31/2015)... ... , ... According to the article published July 27 on My News LA, a ... extinguished by the city’s fire department before it caused major damage throughout the building. The ... fire, and it was a fire alarm system that tipped off fire fighters so they ...
Breaking Medicine News(10 mins):Health News:March4thforWellBeing Foundation Kickoff 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 3
... Feb. 10 B. Braun Medical Inc. (B. ... pain management as well as a pioneer in ... announced today that it has been awarded a ... both hemodialysis and continuous renal replacement therapy (CRRT) ...
... Hospitals Help Set Unprecedented NumbersVIRGINIA BEACH, Va., Feb. ... was able to save the lives of 406 ... in 2008.LifeNet Health saw a 13% increase from ... supplied to hospitals and physicians. LifeNet Health ...
... Valentine,s Day often includes expensive dinners and fattening candy ... of a recent American Heart Association survey suggest couples ... -- walks on the beach, in a park and ... connected with their significant other while on a walk ...
... SurgiQuest, Inc. AirSeal Dynamic Pressure System(TM) was ... AirSeal DPS(TM) continuously re-circulates and filters CO2 used ... routinely have to interrupt laparoscopic surgical procedures due ... plume within the operative environment. This impairment restricts ...
... Industry Leaders Team up to Drive Performance Improvements ... ( www.activplant.com ) announced today that GlaxoSmithKline PLC ... Activplant as a recommended business intelligence solution for ... a successful implementation where GSK experienced the ease ...
... LLC, as the new publishing company for JNCCN - ... Spring Publishing is a newly formed medical publishing company ... Conor Lynch. Content in JNCCN covers the entire spectrum ... Clinical Practice Guidelines in Oncology(TM).FORT WASHINGTON, Pa., Feb. 10 ...
Cached Medicine News:Health News:B. Braun Wins Premier Contract for Full Line of Dialysis Products 2Health News:B. Braun Wins Premier Contract for Full Line of Dialysis Products 3Health News:LifeNet Health Announces a Record Year of Saving Lives and Restoring Health 2Health News:LifeNet Health Announces a Record Year of Saving Lives and Restoring Health 3Health News:American Heart Association Survey: Romance and Walking a Perfect Match 2Health News:SurgiQuest Announces FDA Approval for Smoke & Plume Evacuation for AirSeal Dynamic Pressure System(TM) 2Health News:Activplant Corporation Announces Global Agreement with GlaxoSmithKline 2Health News:JNCCN Names New Publishing Company 2Health News:JNCCN Names New Publishing Company 3
(Date:7/31/2015)... 2015 According to a new market ... Dry Heat, Ethylene Oxide, Filtration, E-beam, Gamma), Services (Onsite & ... - Global Forecast to 2020", published by MarketsandMarkets, The Sterilization ... by 2020, at a CAGR of 7.6%.from 2015 to 2020. ... data T ables and 37 ...
(Date:7/31/2015)... N.J. and SAN DIEGO ... that its parent company Eisai Co., Ltd. (Headquarters: ... Naito , "Eisai") and Halozyme Therapeutics, Inc. (Headquarters: ... Dr. Helen Torley , "NASDAQ: HALO") have signed ... (brand name: Halaven ® , "eribulin") in combination with ...
(Date:7/30/2015)... -- Mettler-Toledo International Inc. (NYSE: MTD ) today ... the highlights: , Sales in local currency ... year. Reported sales decreased 4% as currency reduced sales ... earnings per diluted share as reported (EPS) were $2.73, ... was $2.80 , an increase of 9% over ...
Breaking Medicine Technology:Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 2Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 3Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14
... is a semi-rigid system intended for ... Slim-LOC is based on the comprehensive, ... market technology. The Slim-LOCTM system offers ... Reduced width (16 mm), low profile ...
... ZephirTM anterior cervical plate system is the ... mm height includes an integrated lock mechanism, ... the bone screws. Surgeons appreciate the narrow ... and dissection required. The system also offers ...
... provider of Telemedicine monitoring and diagnostic ... service commitment to patients and prescribing ... testing devices that provide enhanced diagnostic ... standard telephone lines. TransMedEx's product line ...
... CardioNet has developed a new, ... which allows heartbeat-by-heartbeat, ECG monitoring, analysis ... 24/7/365. Our service is initially focused ... patients with arrhythmia. Time is of ...
Medicine Products: